Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 4 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Sarcoma 1 Neoplasm Invasiveness 1 Myofibroma 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Disease 1 Carcinoma, Ovarian Epithelial 1

Interventions

Blood Specimen Collection 9 Surveys and Questionnaires 5 Magnetic Resonance Spectroscopy 5 Biopsy 5 Prednisone 4 Colonoscopy 4 Biopsy, Fine-Needle 4 Tomography, X-Ray Computed 3 Surgical Procedures, Operative 3 Mammography 3 Magnetic Resonance Imaging 3 Liquid Biopsy 3 Lenalidomide 3 Interviews as Topic 3 Exercise 3 Diagnostic Tests, Routine 3 Cyclophosphamide 3 weifuchun 2 pembrolizumab 2 obinutuzumab 2 Urination 2 Preoperative Exercise 2 Positron Emission Tomography Computed Tomography 2 Observation 2 Methods 2 Melphalan 2 Immunohistochemistry 2 Hematologic Tests 2 Gemcitabine 2 Educational Status 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Disease × CA-125 Antigen × Clear all

NCT02296307 2024-05-02

DOvEE

McGill University

13,600 enrolled

Disease, Neoplasm Invasiveness, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡